Orstanorm en es it fr

Orstanorm Brand names, Orstanorm Analogs

Orstanorm Brand Names Mixture

  • No information avaliable

Orstanorm Chemical_Formula

C33H37N5O5

Orstanorm RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Orstanorm fda sheet

Orstanorm FDA

Orstanorm msds (material safety sheet)

Orstanorm MSDS

Orstanorm Synthesis Reference

No information avaliable

Orstanorm Molecular Weight

583.678 g/mol

Orstanorm Melting Point

No information avaliable

Orstanorm H2O Solubility

No information avaliable

Orstanorm State

Solid

Orstanorm LogP

No information avaliable

Orstanorm Dosage Forms

Liquid

Orstanorm Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Orstanorm Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Orstanorm Absorption

Interpatient variable and may be dependent on the administration technique

Orstanorm side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Orstanorm Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Orstanorm Organisms Affected

Humans and other mammals